On the functional overlap between complement and anti-microbial peptides

Frontiers in Immunology

Volumn 6, Issue JAN, 2015, Pages

  Zimmer, Jana ^a   Hobkirk, James ^b   Mohamed, Fatima ^c   Browning, Michael J ^c,d   Stover, Cordula M ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HULL   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Acute inflammation; Deficiencies; Histidine tag; Immune cells; Innate immunity

Indexed keywords

ALPHA DEFENSIN; BETA DEFENSIN; CHEMOATTRACTANT; COMPLEMENT; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT COMPONENT C5B; COMPLEMENT COMPONENT C9; COMPLEMENT FACTOR H; ENDOTOXIN; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 23; LIPOPOLYSACCHARIDE; MESSENGER RNA; POLYPEPTIDE ANTIBIOTIC AGENT;

ANTIMICROBIAL ACTIVITY; APPENDICITIS; CELL FUNCTION; COMPLEMENT ACTIVATION; COMPLEMENT DEFICIENCY; GROWTH INHIBITION; HUMAN; IMMUNE RESPONSE; INFECTION; INFLAMMATION; INNATE IMMUNITY; ISCHEMIA; LYSIS; MACROPHAGE; MONOCYTE; NONHUMAN; PATHOGENESIS; PERITONITIS; PHAGOCYTOSIS; PROTEIN EXPRESSION; REVIEW; SYNTHESIS; UPREGULATION;

EID: 84926674439     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00689     Document Type: Review

References (159)

1. Rus H, Cudrici C, Niculescu F. The role of the complement system in innate immunity. Immunol Res (2005) 33:103-12. doi: 10.1385/IR:33:2:103.
2. Hajishengallis G, Lambris JD. Crosstalk pathways between toll-like receptors and the complement system. Trends Immunol (2010) 31:154-63. doi:10.1016/j.it.2010.01.002.
3. Zipfel PF, Skerka C. Complement regulators and inhibitory proteins. Nat Rev Immunol (2009) 9:729-40. doi:10.1038/nri2620.
4. Thurman JM, Renner B. Dynamic control of the complement system by modulated expression of regulatory proteins. Lab Invest (2011) 91:4-11. doi:10.1038/labinvest.2010.173.
5. Kouser L, Abdul-Aziz M, Nayak A, Stover CM, Sim RB, Kishore U. Properdin and factor h: opposing players on the alternative complement pathway "see-saw". Front Immunol (2013) 4:93. doi:10.3389/fimmu.2013.00093.
6. Harwig SS, Park AS, Lehrer RI. Characterization of defensin precursors in mature human neutrophils. Blood (1992) 79:1532-7.
7. Wilde CG, Snable JL, Griffith JE, Scott RW. Characterization of two azurophil granule proteases with active-site homology to neutrophil elastase. J Biol Chem (1990) 265:2038-41.
8. Sengeløv H, Follin P, Kjeldsen L, Lollike K, Dahlgren C, Borregaard N. Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils. J Immunol (1995) 154:4157-65.
9. Jones DE, Bevins CL. Paneth cells of the human small intestine express an antimicrobial peptide gene. J Biol Chem (1992) 267:23216-25.
10. O'Neil DA, Porter EM, Elewaut D, Anderson GM, Eckmann L, Ganz T, et al. Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol (1999) 163:6718-24.
11. Menzies BE, Kenoyer A. Staphylococcus aureus infection of epidermal keratinocytes promotes expression of innate antimicrobial peptides. Infect Immun (2005) 73:5241-4. doi:10.1128/IAI.73.8.5241-5244.2005.
12. Wehkamp J, Stange EF. Paneth cells and the innate immune response. Curr Opin Gastroenterol (2006) 22:644-50. doi:10.1097/01.mog.0000245541.95408.86.
13. Zanger P, Holzer J, Schleucher R, Steffen H, Schittek B, Gabrysch S. Constitutive expression of the antimicrobial peptide RNase 7 is associated with Staphylococcus aureus infection of the skin. J Infect Dis (2009) 200:1907-15. doi:10.1086/648408.
14. Röhrl J, Yang D, Oppenheim JJ, Hehlgans T. Specific binding and chemotactic activity of mBD4 and its functional orthologue hBD2 to CCR6-expressing cells. J Biol Chem (2010) 285:7028-34. doi:10.1074/jbc. M109.091090.
15. De Paula VS, Pomin VH, Valente AP. Unique properties of human β-defensin 6 (hBD6) and glycosaminoglycan complex: sandwich-like dimerization and competition with the chemokine receptor 2 (CCR2) binding site. J Biol Chem (2014) 289:22969-79. doi:10.1074/jbc. M114.572529.
16. De Yang Chen Q, Schmidt AP, Anderson GM, Wang JM, Wooters J, et al. LL-37, the neutrophil granule-and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med (2000) 192:1069-74. doi:10.1084/jem.192.7.1069.
17. Elssner A, Duncan M, Gavrilin M, Wewers MD. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J Immunol (2004) 172:4987-94. doi:10.4049/jimmunol.172.8.4987.
18. Lau YE, Rozek A, Scott MG, Goosney DL, Davidson DJ, Hancock REW. Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells. Infect Immun (2005) 73:583-91. doi:10.1128/IAI.73.1.583-591.2005.
19. Morris KM, Aden DP, Knowles BB, Colten HR. Complement biosynthesis by the human hepatoma-derived cell line HepG2. J Clin Invest (1982) 70:906-13. doi:10.1172/JCI110687.
20. Morgan BP, Gasque P. Extrahepatic complement biosynthesis: where, when and why? Clin Exp Immunol (1997) 107:1-7. doi:10.1046/j.1365-2249.1997.d01-890.x.
21. Mandal MNA, Ayyagari R. Complement factor H: spatial and temporal expression and localization in the eye. Invest Ophthalmol Vis Sci (2006) 47:4091-7. doi:10.1167/iovs.05-1655.
22. Johnson E, Hetland G. Mononuclear phagocytes have the potential to synthesize the complete functional complement system. Scand J Immunol (1988) 27:489-93. doi:10.1111/j.1365-3083.1988.tb02375.x.
23. Garred P, Hetland G, Mollnes TE, Stoervold G. Synthesis of C3, C5, C6, C7, C8, and C9 by human fibroblasts. Scand J Immunol (1990) 32:555-60. doi:10.1111/j.1365-3083.1990.tb03196.x.
24. Langeggen H, Pausa M, Johnson E, Casarsa C, Tedesco F. The endothelium is an extrahepatic site of synthesis of the seventh component of the complement system. Clin Exp Immunol (2000) 121:69-76. doi:10.1046/j.1365-2249.2000.01238.x.
25. Brooimans RA, Stegmann AP, van Dorp WT, van der Ark AA, van der Woude FJ, van Es LA, et al. Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. J Clin Invest (1991) 88:379-84. doi:10.1172/JCI115314.
26. Andoh A, Fujiyama Y, Sakumoto H, Uchihara H, Kimura T, Koyama S, et al. Detection of complement C3 and factor B gene expression in normal colorectal mucosa, adenomas and carcinomas. Clin Exp Immunol (1998) 111:477-83. doi:10.1046/j.1365-2249.1998.00496.x.
27. Griffiths MR, Neal JW, Fontaine M, Das T, Gasque P. Complement factor H, a marker of self protects against experimental autoimmune encephalomyelitis. J Immunol (2009) 182:4368-77. doi:10.4049/jimmunol.0800205.
28. Pattrick M, Luckett J, Yue L, Stover C. Dual role of complement in adipose tissue. Mol Immunol (2009) 46:755-60. doi:10.1016/j.molimm.2008.09.013.
29. Hosszu KK, Valentino A, Ji Y, Matkovic M, Pednekar L, Rehage N, et al. Cell surface expression and function of the macromolecular c1 complex on the surface of human monocytes. Front Immunol (2012) 3:38. doi:10.3389/fimmu.2012.00038.
30. Camous L, Roumenina L, Bigot S, Brachemi S, Frémeaux-Bacchi V, Lesavre P, et al. Complement alternative pathway acts as a positive feedback amplification of neutrophil activation. Blood (2011) 117:1340-9. doi:10.1182/blood-2010-05-283564.
31. Whaley K. Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes. J Exp Med (1980) 151:501-16. doi:10.1084/jem.151.3.501.
32. Bongrazio M, Pries AR, Zakrzewicz A. The endothelium as physiological source of properdin: role of wall shear stress. Mol Immunol (2003) 39:669-75. doi:10.1016/S0161-5890(02)00215-8.
33. Kemper C, Mitchell LM, Zhang L, Hourcade DE. The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosis. Proc Natl Acad Sci USA (2008) 105:9023-8. doi:10.1073/pnas.0801015105.
34. Xu W, Berger SP, Trouw LA, de Boer HC, Schlagwein N, Mutsaers C, et al. Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation. J Immunol (2008) 180:7613-21. doi:10.4049/jimmunol.180.11.7613.
35. Kemper C, Atkinson JP, Hourcade DE. Properdin: emerging roles of a pattern-recognition molecule. Annu Rev Immunol (2010) 28:131-55. doi:10.1146/annurev-immunol-030409-101250.
36. Grailer JJ, Bosmann M, Ward PA. Regulatory effects of C5a on IL-17A, IL-17F, and IL-23. Front Immunol (2012) 3:387. doi:10.3389/fimmu.2012.00387.
37. Lajoie S, Lewkowich IP, Suzuki Y, Clark JR, Sproles AA, Dienger K, et al. Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat Immunol (2010) 11:928-35. doi:10.1038/ni.1926.
38. Tang S, Zhou W, Sheerin NS, Vaughan RW, Sacks SH. Contribution of renal secreted complement C3 to the circulating pool in humans. J Immunol (1999) 162:4336-41.
39. Laufer J, Katz Y, Passwell JH. Extrahepatic synthesis of complement proteins in inflammation. Mol Immunol (2001) 38:221-9. doi:10.1016/S0161-5890(01)00044-X.
40. Kolev M, Friec GL, Kemper C. Complement-tapping into new sites and effector systems. Nat Rev Immunol (2014) 14:811-20. doi:10.1038/nri3761.
41. Ouellette AJ, Hsieh MM, Nosek MT, Cano-Gauci DF, Huttner KM, Buick RN, et al. Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms. Infect Immun (1994) 62:5040-7.
42. Geyer G. Lysozyme in Paneth cell secretions. Acta Histochem (1973) 45:126-32.
43. Mulherkar R, Rao RS, Wagle AS, Patki V, Deo MG. Enhancing factor, a Paneth cell specific protein from mouse small intestines: predicted amino acid sequence from RT-PCR amplified cDNA and its expression. Biochem Biophys Res Commun (1993) 197:351-2. doi:10.1006/bbrc.1993.2485.
44. Selsted ME, Miller SI, Henschen AH, Ouellette AJ. Enteric defensins: antibiotic peptide components of intestinal host defense. J Cell Biol (1992) 118:929-36. doi:10.1083/jcb.118.4.929.
45. Ouellette AJ. Paneth cell alpha-defensin synthesis and function. Curr Top Microbiol Immunol (2006) 306:1-25. doi:10.1007/3-540-29916-5_1.
46. Ouellette AJ. Paneth cells and innate immunity in the crypt microenvironment. Gastroenterology (1997) 113:1779-84. doi:10.1053/gast.1997.v113.pm9352884.
47. Saberwal G, Nagaraj R. Cell-lytic and antibacterial peptides that act by perturbing the barrier function of membranes: facets of their conformational features, structure-function correlations and membrane-perturbing abilities. Biochim Biophys Acta (1994) 1197:109-31. doi:10.1016/0304-4157(94)90002-7.
48. Hancock JT. Superoxide, hydrogen peroxide and nitric oxide as signalling molecules: their production and role in disease. Br J Biomed Sci (1997) 54:38-46.
49. Müller-Eberhard HJ. The membrane attack complex of complement. Annu Rev Immunol (1986) 4:503-28. doi:10.1146/annurev.immunol.4.1.503.
50. Lovelace LL, Cooper CL, Sodetz JM, Lebioda L. Structure of human C8 protein provides mechanistic insight into membrane pore formation by complement. J Biol Chem (2011) 286:17585-92. doi:10.1074/jbc. M111.219766.
51. Pasupuleti M, Schmidtchen A, Malmsten M. Antimicrobial peptides: key components of the innate immune system. Crit Rev Biotechnol (2012) 32:143-71. doi:10.3109/07388551.2011.594423.
52. Laarman A, Milder F, van Strijp J, Rooijakkers S. Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications. J Mol Med (2010) 88:115-20. doi:10.1007/s00109-009-0572-y.
53. Nizet V. Antimicrobial peptide resistance mechanisms of human bacterial pathogens. Curr Issues Mol Biol (2006) 8:11-26.
54. Pasupuleti M, Walse B, Nordahl EA, Mörgelin M, Malmsten M, Schmidtchen A. Preservation of antimicrobial properties of complement peptide C3a, from invertebrates to humans. J Biol Chem (2007) 282:2520-8. doi:10.1074/jbc. M607848200.
55. Sonesson A, Ringstad L, Nordahl EA, Malmsten M, Mörgelin M, Schmidtchen A. Antifungal activity of C3a and C3a-derived peptides against Candida. Biochim Biophys Acta (2007) 1768:346-53. doi:10.1016/j.bbamem.2006.10.017.
56. Grupp A, Kimmel M, Fritz P, Voggenreiter B, Stöltzing H, Kuhlmann U, et al. The expression patterns of peritoneal defensins. Perit Dial Int (2007) 27:654-62.
57. Bazargani F, Albrektsson A, Yahyapour N, Braide M. Low molecular weight heparin improves peritoneal ultrafiltration and blocks complement and coagulation. Perit Dial Int (2005) 25:394-404.
58. Zarrinkalam KH, Leavesley DI, Stanley JM, Atkins GJ, Faull RJ. Expression of defensin antimicrobial peptides in the peritoneal cavity of patients on peritoneal dialysis. Perit Dial Int (2001) 21:501-8.
59. Wan M, van der Does AM, Tang X, Lindbom L, Agerberth B, Haeggström JZ. Antimicrobial peptide LL-37 promotes bacterial phagocytosis by human macrophages. J Leukoc Biol (2014) 95:971-81. doi:10.1189/jlb.0513304.
60. Honczarenko M, Ratajczak MZ, Nicholson-Weller A, Silberstein LE. Complement C3a enhances CXCL12 (SDF-1)-mediated chemotaxis of bone marrow hematopoietic cells independently of C3a receptor. J Immunol (2005) 175:3698-706. doi:10.4049/jimmunol.175.6.3698.
61. Dobó J, Major B, Kékesi KA, Szabó I, Megyeri M, Hajela K, et al. Cleavage of kininogen and subsequent bradykinin release by the complement component: mannose-binding lectin-associated serine protease (MASP)-1. PLoS One (2011) 6:e20036. doi:10.1371/journal.pone.0020036.
62. Kohidai L, Kovács K, Csaba G. Direct chemotactic effect of bradykinin and related peptides-significance of amino-and carboxyterminal character of oligopeptides in chemotaxis of tetrahymena pyriformis. Cell Biol Int (2002) 26:55-62. doi:10.1006/cbir.2001.0809.
63. Oppenheim JJ, Biragyn A, Kwak LW, Yang D. Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann Rheum Dis (2003) 62(Suppl 2):ii17-21. doi:10.1136/ard.62.suppl_2.ii17.
64. Dempsey PW, Allison ME, Akkaraju S, Goodnow CC, Fearon DT. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science (1996) 271:348-50. doi:10.1126/science.271.5247.348.
65. Glovsky MM, Ward PA, Johnson KJ. Complement determinations in human disease. Ann Allergy Asthma Immunol (2004) 93:513-22. doi:10.1016/S1081-1206(10)61257-4.
66. Hancock RE, Diamond G. The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol (2000) 8:402-10. doi:10.1016/S0966-842X(00)01823-0.
67. Koyasu S, Moro K. Role of innate lymphocytes in infection and inflammation. Front Immunol (2012) 3:101. doi:10.3389/fimmu.2012.00101.
68. Liang SC, Tan X-Y, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med (2006) 203:2271-9. doi:10.1084/jem.20061308.
69. Weaver DJ, Reis ES, Pandey MK, Köhl G, Harris N, Gerard C, et al. C5a receptor-deficient dendritic cells promote induction of Treg and Th17 cells. Eur J Immunol (2010) 40:710-21. doi:10.1002/eji.200939333.
70. Asgari E, Le Friec G, Yamamoto H, Perucha E, Sacks SS, Köhl J, et al. C3a modulates IL-1β secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation. Blood (2013) 122:3473-81. doi:10.1182/blood-2013-05-502229.
71. Dupont A, Mohamed F, Salehen N, Glenn S, Francescut L, Adib R, et al. Septicaemia models using Streptococcus pneumoniae and Listeria monocytogenes: understanding the role of complement properdin. Med Microbiol Immunol (2014) 203:257-71. doi:10.1007/s00430-013-0324-z.
72. Fang C, Zhang X, Miwa T, Song W-C. Complement promotes the development of inflammatory T-helper 17 cells through synergistic interaction with toll-like receptor signaling and interleukin-6 production. Blood (2009) 114:1005-15. doi:10.1182/blood-2009-01-198283.
73. van der Does AM, Joosten SA, Vroomans E, Bogaards SJP, van Meijgaarden KE, Ottenhoff THM, et al. The antimicrobial peptide hLF1-11 drives monocyte-dendritic cell differentiation toward dendritic cells that promote antifungal responses and enhance Th17 polarization. J Innate Immun (2012) 4:284-92. doi:10.1159/000332941.
74. Cunningham PN, Holers VM, Alexander JJ, Guthridge JM, Carroll MC, Quigg RJ. Complement is activated in kidney by endotoxin but does not cause the ensuing acute renal failure. Kidney Int (2000) 58:1580-7. doi:10.1046/j.1523-1755.2000.00319.x.
75. Song WC. Crosstalk between complement and toll-like receptors. Toxicol Pathol (2012) 40:174-82. doi:10.1177/0192623311428478.
76. Giuliani A, Pirri G, Rinaldi AC. Antimicrobial peptides: the LPS connection. Methods Mol Biol (2010) 618:137-54. doi:10.1007/978-1-60761-594-1_10.
77. Ren J, Zhao Y, Yuan Y, Han G, Li W, Huang Q, et al. Complement depletion deteriorates clinical outcomes of severe abdominal sepsis: a conspirator of infection and coagulopathy in crime? PLoS One (2012) 7:e47095. doi:10.1371/journal.pone.0047095.
78. Book M, Chen Q, Lehmann LE, Klaschik S, Weber S, Schewe JC, et al. Inducibility of the endogenous antibiotic peptide beta-defensin 2 is impaired in patients with severe sepsis. Crit Care (2007) 11:R19. doi:10.1186/cc5694.
79. Amrein K, Zajic P, Schnedl C, Waltensdorfer A, Fruhwald S, Holl A, et al. Vitamin D status and its association with season, hospital and sepsis mortality in critical illness. Crit Care (2014) 18:R47. doi:10.1186/cc13790.
80. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, et al. Cutting edge: 1, 25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol (2004) 173:2909-12. doi:10.4049/jimmunol.173.10.6490-c.
81. Littman BH, Sanders KM. Effects of vitamin D3 and IFN-gamma on the synthesis of the second complement component, C2, by a human myeloid leukemia (HL-60) cell line. J Immunol (1988) 140:3082-5.
82. Tsukamoto H, Nagasawa K, Ueda Y, Mayumi T, Furugo I, Tsuru T, et al. Effects of cell differentiation on the synthesis of the third and fourth component of complement (C3, C4) by the human monocytic cell line U937. Immunology (1992) 77:621-3.
83. Riedemann NC, Guo R-F, Neff TA, Laudes IJ, Keller KA, Sarma VJ, et al. Increased C5a receptor expression in sepsis. J Clin Invest (2002) 110:101-8. doi:10.1172/JCI200215409.
84. Daigneault M, Preston JA, Marriott HM, Whyte MKB, Dockrell DH. The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One (2010) 5:e8668. doi:10.1371/journal.pone.0008668.
85. Bengio S, Gilbert D, Peulve P, Daveau M, Fontaine M. Biosynthesis of the third component of complement (C3) by the human monocytic-cell line U-937. Induction by phorbol myristate acetate. Biochem J (1986) 239:711-6.
86. Strunk RC, Kunke KS, Giclas PC. Human peripheral blood monocyte-derived macrophages produce haemolytically active C3 in vitro. Immunology (1983) 49:169-74.
87. Høgåsen AK, Abrahamsen TG. Heparin suppresses lipopolysaccharide-induced monocyte production of several cytokines, but simultaneously stimulates C3 production. Thromb Res (1995) 80:179-84. doi:10.1016/0049-3848(95)00164-M.
88. Cole FS, Schneeberger EE, Lichtenberg NA, Colten HR. Complement biosynthesis in human breast-milk macrophages and blood monocytes. Immunology (1982) 46:429-41.
89. Minta JO, Isenman DE. Biosynthesis of the third component of complement by the human monocyte-like cell line, U-937. Mol Immunol (1987) 24:1105-11. doi:10.1016/0161-5890(87)90079-4.
90. Goodrum KJ. Complement component C3 secretion by mouse macrophage-like cell lines. J Leukoc Biol (1987) 41:295-301.
91. Mogilenko DA, Kudriavtsev IV, Trulioff AS, Shavva VS, Dizhe EB, Missyul BV, et al. Modified low density lipoprotein stimulates complement C3 expression and secretion via liver X receptor and Toll-like receptor 4 activation in human macrophages. J Biol Chem (2012) 287:5954-68. doi:10.1074/jbc. M111.289322.
92. van Furth R, van Schadewijk-Nieuwstad M, Elzenga-Claasen I, Cornelisse C, Nibbering P. Morphological, cytochemical, functional, and proliferative characteristics of four murine macrophage-like cell lines. Cell Immunol (1985) 90:339-57. doi:10.1016/0008-8749(85)90199-6.
93. Tavano R, Segat D, Gobbo M, Papini E. The honeybee antimicrobial peptide apidaecin differentially immunomodulates human macrophages, monocytes and dendritic cells. J Innate Immun (2011) 3:614-22. doi:10.1159/000327839.
94. Van der Does AM, Bogaards SJP, Ravensbergen B, Beekhuizen H, van Dissel JT, Nibbering PH. Antimicrobial peptide hLF1-11 directs granulocyte-macrophage colony-stimulating factor-driven monocyte differentiation toward macrophages with enhanced recognition and clearance of pathogens. Antimicrob Agents Chemother (2010) 54:811-6. doi:10.1128/AAC.00652-09.
95. Van der Does AM, Beekhuizen H, Ravensbergen B, Vos T, Ottenhoff THM, van Dissel JT, et al. LL-37 directs macrophage differentiation toward macrophages with a proinflammatory signature. J Immunol (2010) 185:1442-9. doi:10.4049/jimmunol.1000376.
96. Fairweather D, Cihakova D. Alternatively activated macrophages in infection and autoimmunity. J Autoimmun (2009) 33:222-30. doi:10.1016/j.jaut.2009.09.012.
97. Fischer MB, Ma M, Hsu NC, Carroll MC. Local synthesis of C3 within the splenic lymphoid compartment can reconstitute the impaired immune response in C3-deficient mice. J Immunol (1998) 160:2619-25.
98. Celada A, Klemsz MJ, Maki RA. Interferon-gamma activates multiple pathways to regulate the expression of the genes for major histocompatibility class II I-A beta, tumor necrosis factor and complement component C3 in mouse macrophages. Eur J Immunol (1989) 19:1103-9. doi:10.1002/eji.1830190621.
99. Mitchell TJ, Naughton M, Norsworthy P, Davies KA, Walport MJ, Morley BJ. IFN-gamma up-regulates expression of the complement components C3 and C4 by stabilization of mRNA. J Immunol (1996) 156:4429-34.
100. Böttger EC, Metzger S, Bitter-Suermann D, Stevenson G, Kleindienst S, Burger R. Impaired humoral immune response in complement C3-deficient guinea pigs: absence of secondary antibody response. Eur J Immunol (1986) 16:1231-5. doi:10.1002/eji.1830161008.
101. Brown KL, Poon GFT, Birkenhead D, Pena OM, Falsafi R, Dahlgren C, et al. Host defense peptide LL-37 selectively reduces proinflammatory macrophage responses. J Immunol (2011) 186:5497-505. doi:10.4049/jimmunol.1002508.
102. Mookherjee N, Brown KL, Bowdish DME, Doria S, Falsafi R, Hokamp K, et al. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J Immunol (2006) 176:2455-64. doi:10.4049/jimmunol.176.4.2455.
103. Bruns H, Fabri M, Maurberger A, Pasemann S, Fahrenwaldt C, Wilke A, et al. M1 macrophages eliminate lymphoma cells through the vitamin D dependent antimicrobial peptide cathelicidin. American Society of Hematology 53rd Annual meeting Dec 10-13. San Diego, USA (2011).
104. Ginhoux F, Jung S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat Rev Immunol (2014) 14:392-404. doi:10.1038/nri3671.
105. Skattum L, van Deuren M, van der Poll T, Truedsson L. Complement deficiency states and associated infections. Mol Immunol (2011) 48:1643-55. doi:10.1016/j.molimm.2011.05.001.
106. Ricklin D, Lambris JD. Complement in immune and inflammatory disorders: pathophysiological mechanisms. J Immunol (2013) 190:3831-8. doi:10.4049/jimmunol.1203200.
107. Lachmann PJ, Smith RAG. Taking complement to the clinic-has the time finally come? Scand J Immunol (2009) 69:471-8. doi:10.1111/j.1365-3083.2009.02258.x.
108. Tzou P, Reichhart J-M, Lemaitre B. Constitutive expression of a single antimicrobial peptide can restore wild-type resistance to infection in immunodeficient Drosophila mutants. Proc Natl Acad Sci USA (2002) 99:2152-7. doi:10.1073/pnas.042411999.
109. Iimura M, Gallo RL, Hase K, Miyamoto Y, Eckmann L, Kagnoff MF. Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J Immunol (2005) 174:4901-7. doi:10.4049/jimmunol.174.8.4901.
110. Huang LC, Reins RY, Gallo RL, McDermott AM. Cathelicidin-deficient (Cnlp-/-) mice show increased susceptibility to Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci (2007) 48:4498-508. doi:10.1167/iovs.07-0274.
111. Chromek M, Arvidsson I, Karpman D. The antimicrobial peptide cathelicidin protects mice from Escherichia coli O157:H7-mediated disease. PLoS One (2012) 7:e46476. doi:10.1371/journal.pone.0046476.
112. Kovach MA, Ballinger MN, Newstead MW, Zeng X, Bhan U, Yu F, et al. Cathelicidin-related antimicrobial peptide is required for effective lung mucosal immunity in Gram-negative bacterial pneumonia. J Immunol (2012) 189:304-11. doi:10.4049/jimmunol.1103196.
113. Merres J, Höss J, Albrecht L-J, Kress E, Soehnlein O, Jansen S, et al. Role of the cathelicidin-related antimicrobial peptide in inflammation and mortality in a mouse model of bacterial meningitis. J Innate Immun (2014) 6:205-18. doi:10.1159/000353645.
114. Pütsep K, Carlsson G, Boman HG, Andersson M. Deficiency of antibacterial peptides in patients with Morbus Kostmann: an observation study. Lancet (2002) 360:1144-9. doi:10.1016/S0140-6736(02)11201-3.
115. Rieg S, Steffen H, Seeber S, Humeny A, Kalbacher H, Dietz K, et al. Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo. J Immunol (2005) 174:8003-10. doi:10.4049/jimmunol.174.12.8003.
116. de Haar SF, Hiemstra PS, van Steenbergen MTJM, Everts V, Beertsen W. Role of polymorphonuclear leukocyte-derived serine proteinases in defense against Actinobacillus actinomycetemcomitans. Infect Immun (2006) 74:5284-91. doi:10.1128/IAI.02016-05.
117. Ehrnthaller C, Ignatius A, Gebhard F, Huber-Lang M. New insights of an old defense system: structure, function, and clinical relevance of the complement system. Mol Med (2011) 17:317-29. doi:10.2119/molmed.2010.00149.
118. Rittirsch D, Redl H, Huber-Lang M. Role of complement in multiorgan failure. Clin Dev Immunol (2012) 2012:962927. doi:10.1155/2012/962927.
119. Charchaflieh J, Wei J, Labaze G, Hou YJ, Babarsh B, Stutz H, et al. The role of complement system in septic shock. Clin Dev Immunol (2012) 2012:1-8. doi:10.1155/2012/407324.
120. Hack CE, Nuijens JH, Felt-Bersma RJ, Schreuder WO, Eerenberg-Belmer AJ, Paardekooper J, et al. Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis. Am J Med (1989) 86:20-6. doi:10.1016/0002-9343(89)90224-6.
121. Gerard C. Complement C5a in the sepsis syndrome-too much of a good thing? N Engl J Med (2003) 348:167-9. doi:10.1056/NEJMcibr022995.
122. Hammerschmidt DE, Weaver LJ, Hudson LD, Craddock PR, Jacob HS. Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Pathophysiological relevance and possible prognostic value. Lancet (1980) 1:947-9. doi:10.1016/S0140-6736(80)91403-8.
123. Collins HL, Bancroft GJ. Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans. Eur J Immunol (1992) 22:1447-54. doi:10.1002/eji.1830220617.
124. Oikonomopoulou K, Ricklin D, Ward PA, Lambris JD. Interactions between coagulation and complement-their role in inflammation. Semin Immunopathol (2012) 34:151-65. doi:10.1007/s00281-011-0280-x.
125. Pedersen ED, Waje-Andreassen U, Vedeler CA, Aamodt G, Mollnes TE. Systemic complement activation following human acute ischaemic stroke. Clin Exp Immunol (2004) 137:117-22. doi:10.1111/j.1365-2249.2004.02489.x.
126. van Beek J, Elward K, Gasque P. Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection. Ann N Y Acad Sci (2003) 992:56-71. doi:10.1111/j.1749-6632.2003.tb03138.x.
127. Osaka H, McGinty A, Höepken UE, Lu B, Gerard C, Pasinetti GM. Expression of C5a receptor in mouse brain: role in signal transduction and neurodegeneration. Neuroscience (1999) 88:1073-82. doi:10.1016/S0306-4522(98)00372-8.
128. Stahel PF, Morganti-Kossmann MC, Kossmann T. The role of the complement system in traumatic brain injury. Brain Res Brain Res Rev (1998) 27:243-56. doi:10.1016/S0165-0173(98)00015-0.
129. Lynch NJ, Willis CL, Nolan CC, Roscher S, Fowler MJ, Weihe E, et al. Microglial activation and increased synthesis of complement component C1q precedes blood-brain barrier dysfunction in rats. Mol Immunol (2004) 40:709-16. doi:10.1016/j.molimm.2003.08.009.
130. Arumugam TV, Shiels IA, Woodruff TM, Granger DN, Taylor SM. The role of the complement system in ischemia-reperfusion injury. Shock (2004) 21:401-9. doi:10.1097/00024382-200405000-00002.
131. Link C, Hawlisch H, Meyer zu Vilsendorf A, Gylerüz S, Nagel E, Köhl J. Selection of phage-displayed anti-guinea pig C5 or C5a antibodies and their application in xenotransplantation. Mol Immunol (1999) 36:1235-47. doi:10.1016/S0161-5890(99)00135-2.
132. Stahl GL, Xu Y, Hao L, Miller M, Buras JA, Fung M, et al. Role for the alternative complement pathway in ischemia/reperfusion injury. Am J Pathol (2003) 162:449-55. doi:10.1016/S0002-9440(10)63839-4.
133. Langlois PF, Gawryl MS. Accentuated formation of the terminal C5b-9 complement complex in patient plasma precedes development of the adult respiratory distress syndrome. Am Rev Respir Dis (1988) 138:368-75. doi:10.1164/ajrccm/138.2.368.
134. Mathey D, Schofer J, Schäfer HJ, Hamdoch T, Joachim HC, Ritgen A, et al. Early accumulation of the terminal complement-complex in the ischaemic myocardium after reperfusion. Eur Heart J (1994) 15:418-23.
135. Väkevä A, Morgan BP, Tikkanen I, Helin K, Laurila P, Meri S. Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium. Am J Pathol (1994) 144:1357-68.
136. Buono C, Come CE, Witztum JL, Maguire GF, Connelly PW, Carroll M, et al. Influence of C3 deficiency on atherosclerosis. Circulation (2002) 105:3025-31. doi:10.1161/01.CIR.0000019584.04929.83.
137. Francescut L, Steiner T, Byrne S, Cianflone K, Francis S, Stover C. The role of complement in the development and manifestation of murine atherogenic inflammation: novel avenues. J Innate Immun (2012) 4:260-72. doi:10.1159/000332435.
138. Hertle E, van Greevenbroek MM, Arts IC, van der Kallen CJ, Geijselaers SL, Feskens EJ, et al. Distinct associations of complement C3a and its precursor C3 with atherosclerosis and cardiovascular disease. The CODAM study. Thromb Haemost (2014) 111:1102-11. doi:10.1160/TH13-10-0831.
139. Liu F, Wu L, Wu G, Wang C, Zhang L, Tomlinson S, et al. Targeted mouse complement inhibitor CR2-Crry protects against the development of atherosclerosis in mice. Atherosclerosis (2014) 234:237-43. doi:10.1016/j.atherosclerosis.2014.03.004.
140. Davidson DJ, Currie AJ, Reid GSD, Bowdish DME, MacDonald KL, Ma RC, et al. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J Immunol (2004) 172:1146-56. doi:10.4049/jimmunol.172.2.1146.
141. Stockinger S, Albers T, Duerr CU, Ménard S, Pütsep K, Andersson M, et al. Interleukin-13-mediated Paneth cell degranulation and antimicrobial peptide release. J Innate Immun (2014) 6:530-41. doi:10.1159/000357644.
142. Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, Dorschner RA, et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature (2001) 414:454-7. doi:10.1038/35106587.
143. Sørensen OE, Cowland JB, Theilgaard-Mönch K, Liu L, Ganz T, Borregaard N. Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol (2003) 170:5583-9. doi:10.4049/jimmunol.170.11.5583.
144. Salzman NH, Underwood MA, Bevins CL. Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa. Semin Immunol (2007) 19:70-83. doi:10.1016/j.smim.2007.04.002.
145. Arlt A, Bharti R, Ilves I, Häsler R, Miettinen P, Paajanen H, et al. Characteristic changes in microbial community composition and expression of innate immune genes in acute appendicitis. Innate Immun (2015) 21:30-41. doi:10.1177/1753425913515033.
146. Nordahl EA, Rydengård V, Nyberg P, Nitsche DP, Mörgelin M, Malmsten M, et al. Activation of the complement system generates antibacterial peptides. Proc Natl Acad Sci U S A (2004) 101:16879-84. doi:10.1073/pnas.0406678101.
147. Malmsten M, Schmidtchen A. Antimicrobial C3a-biology, biophysics, and evolution. Adv Exp Med Biol (2007) 598:141-58. doi:10.1007/978-0-387-71767-8_11.
148. Rydengård V, Andersson Nordahl E, Schmidtchen A. Zinc potentiates the antibacterial effects of histidine-rich peptides against Enterococcus faecalis. FEBS J (2006) 273:2399-406. doi:10.1111/j.1742-4658.2006.05246.x.
149. Lai R, Takeuchi H, Lomas LO, Jonczy J, Rigden DJ, Rees HH, et al. A new type of antimicrobial protein with multiple histidines from the hard tick, Amblyomma hebraeum. FASEB J (2004) 18:1447-9. doi:10.1096/fj.03-1154fje.
150. Ferrer-Miralles N, Corchero JL, Kumar P, Cedano JA, Gupta KC, Villaverde A, et al. Biological activities of histidine-rich peptides; merging biotechnology and nanomedicine. Microb Cell Fact (2011) 10:101. doi:10.1186/1475-2859-10-101.
151. Singh PK, Tack BF, McCray PB, Welsh MJ. Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am J Physiol Lung Cell Mol Physiol (2000) 279:L799-805.
152. Nordahl EA, Rydengård V, Mörgelin M, Schmidtchen A. Domain 5 of high molecular weight kininogen is antibacterial. J Biol Chem (2005) 280:34832-9. doi:10.1074/jbc. M507249200.
153. Qu H, Chen B, Peng H, Wang K. Molecular cloning, recombinant expression, and antimicrobial activity of EC-hepcidin3, a new four-cysteine hepcidin isoform from Epinephelus coioides. Biosci Biotechnol Biochem (2013) 77:103-10. doi:10.1271/bbb.120600.
154. Ali YM, Hayat A, Saeed BM, Haleem KS, Alshamrani S, Kenawy HI, et al. Low-dose recombinant properdin provides substantial protection against Streptococcus pneumoniae and Neisseria meningitidis infection. Proc Natl Acad Sci USA (2014) 111:5301-6. doi:10.1073/pnas.1401011111.
155. Rowinska-Zyrek M, Witkowska D, Potocki S, Remelli M, Kozlowski H. His-rich sequences-is plagiarism from nature a good idea? New J Chem (2013) 37:58. doi:10.1039/c2nj40558j.
156. Frick I-M, Akesson P, Herwald H, Mörgelin M, Malmsten M, Nägler DK, et al. The contact system-a novel branch of innate immunity generating antibacterial peptides. EMBO J (2006) 25:5569-78. doi:10.1038/sj.emboj.7601422.
157. Han YN, Komiya M, Iwanaga S, Suzuki T. Studies on the primary structure of bovine high-molecular-weight kininogen. Amino acid sequence of a fragment ("histidine-rich peptide") released by plasma kallikrein. J Biochem (1975) 77:55-68.
158. Jeng L, Yamshchikov AV, Judd SE, Blumberg HM, Martin GS, Ziegler TR, et al. Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med (2009) 7:28. doi:10.1186/1479-5876-7-28.
159. Bilku D, Zimmer J, Hall T, Chung W, Stover C, Dennison A. Effect of parenteral omega-3 fish oil on C3 levels and mortality in septic patients on intensive care unit. Int J Surg (2013) 11:655. doi:10.1016/j.ijsu.2013.06.368.